Cannabis in painful HIV-associated sensory neuropathy

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neurology

• Publication date

  2007-02-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/01.wnl.0000253187.66183.9cPMID 17296917
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabis use in HIV for pain and other medical symptoms.

  2005cited by this paper
• Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.

  2005cited by this paper
• Algorithm for neuropathic pain treatment: An evidence based proposal

  2005cited by this paper
• Neurological complications of HIV infection.

  2005cited by this paper
• Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

  2005cited by this paper
• Algorithm for neuropathic pain treatment: An evidence based proposal

  2005cited by this paper
• Analgesic activity of δ9-tetrahydrocannabinol in the rat and mouse

  2004cited by this paper
• A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies

  2004cited by this paper
• Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

  2004cited by this paper
• Are oral cannabinoids safe and effective in refractory neuropathic pain?

  2004cited by this paper
• Psychopharmacological activity of the active constituents of hashish and some related cannabinoids

  2004cited by this paper
• Lamotrigine for HIV-associated painful sensory neuropathies

  2003cited by this paper
• Oral opioid therapy for chronic peripheral and central neuropathic pain.

  2003cited by this paper
• The heat/capsaicin sensitization model: a methodologic study.

  2003influential reference
• A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization.

  2003cited by this paper
• Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection

  2003cited by this paper
• The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.

  2002cited by this paper
• Cannabinoid analgesia.

  2002cited by this paper
• Gabapentin Suppresses Cutaneous Hyperalgesia following Heat-Capsaicin Sensitization

  2002cited by this paper
• Clinical importance of changes in chronic pain intensity measured on an 11‐point numerical pain rating scale

  2001cited by this paper
• Effect of Remifentanil on Pain and Secondary Hyperalgesia Associated with the Heat–Capsaicin Sensitization Model in Healthy Volunteers

  2001cited by this paper
• Carbamazepine–Indinavir Interaction Causes Antiretroviral Therapy Failure

  2000cited by this paper
• Topical capsaicin in the management of HIV-associated peripheral neuropathy.

  2000cited by this paper
• A new human experimental pain model: the heat/capsaicin sensitization model.

  1999cited by this paper
• Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial

  1999cited by this paper
• The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats.

  1999cited by this paper
• Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

  1998cited by this paper
• Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial.

  1998cited by this paper
• Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

  1998cited by this paper
• Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.

  1998cited by this paper
• A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection

  1998cited by this paper
• Neurological complications of HIV infection.

  1998cited by this paper
• Control of pain initiation by endogenous cannabinoids

  1998cited by this paper
• The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain.

  1997cited by this paper
• Peptide T in the treatment of painful distal neuropathy associated with AIDS

  1996cited by this paper
• Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey.

  1988cited by this paper
• Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.

  1988cited by this paper
• Tonic analgesic effects of Δ9-tetrahydrocannabinol as measured with the formalin test

  1980cited by this paper
• Tonic analgesic effects of delta 9-tetrahydrocannabinol as measured with the formalin test.

  1980cited by this paper
• Marijuana-produced changes in pain tolerance. Experienced and non-experienced subjects.

  1975cited by this paper
• The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine

  1975cited by this paper
• Cannabis analgesia.

  1974cited by this paper
• The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice

  1973cited by this paper
• Correlations between pathological changes in the hind paws of rats with adjuvant arthritis and their response to anti-inflammatory and analgesic drugs.

  1973cited by this paper
• Manual for the Profile of Mood States

  1971cited by this paper

• O uso medicinal da Cannabis no controle da dor crônica não oncológica: uma revisão narrativa

  2026cites this paper
• Therapeutic Use of Cannabinoids in Age-Related Pain: Current Evidence and Clinical Perspectives.

  2026cites this paper
• Cannabis-based medicines for chronic neuropathic pain in adults.

  2026cites this paper
• Medical cannabis authorization and opioid milligram equivalents over time in patients with chronic pain: a retrospective analysis

  2025cites this paper
• Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines

  2025cites this paper
• A COMPREHENSIVE ANALYSIS OF CANNABIS’S THERAPEUTIC POTENTIAL IN RELATION TO THE HUMAN BODY

  2025cites this paper
• Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks

  2025cites this paper
• Cannabis concentrate vaping chemistry

  2025cites this paper
• Cannabis and Cannabinoids: A Primer

  2025cites this paper
• Detecting and understanding potential stigma among medical cannabis users in Germany

  2025cites this paper
• Cannabis and liver transplant in the era of legalization: Effects of pre-transplant cannabis use on postoperative opioid use and transplant outcomes.

  2025cites this paper
• Beyond the High: Exploring Socioecological Influences on Cannabis Use in Older Women with and without HIV.

  2025cites this paper
• Cannabis Use Trajectories Among People Living With HIV in the Decade Prior to Recreational Legalization in Ontario, Canada (2008-2017).

  2025cites this paper
• Oral Cannabis for Taxane-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Study

  2025cites this paper
• Are Cannabis-Based Medicines a Useful Treatment for Neuropathic Pain? A Systematic Review

  2025influential citation
• Pilot Study on the Effect of Cannabidiol-Coated Fabric for Pillow Covers Improves the Sleep Quality of Shift Nurses

  2025influential citation
• Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial

  2025cites this paper
• Effectiveness of Full Spectrum Cannabis Extracts in the Treatment of Chronic Pain: An Open Label Study

  2025cites this paper
• Efficiency of cannabis and cannabidiol in managing chronic pain syndromes: A comprehensive narrative review.

  2024cites this paper
• Topical Cannabidiol for Established Chemotherapy-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Trial

  2024cites this paper
• CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions

  2024cites this paper
• Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

  2024cites this paper
• Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

  2024cites this paper
• Cannabis Use, Perspectives, and Experiences Among Patients Receiving Hemodialysis: A Descriptive Patient Survey

  2024cites this paper
• Feasibility of a Randomized, Interventional Pilot Clinical Study of Oral Cannabinoids in People with HIV on Antiretroviral Therapy: CTNPT 028

  2024cites this paper
• Leveraging Genetics to Support Forensic Toxicology Analysis: Demonstrating Concordance Among Marijuana Samples

  2024cites this paper
• Cannabis Use and Cannabidiol Modulate HIV-Induced Alterations in TREM2 Expression: Implications for Age-Related Neuropathogenesis

  2024cites this paper
• Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review

  2024cites this paper
• The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects

  2024cites this paper
• Nanocarriers for Cannabinoid Delivery: Enhancing Therapeutic Potential.

  2024cites this paper
• The Use of Cannabinoids in the Treatment of Peripheral Neuropathy and Neuropathic Pain: A Systematic Review.

  2024cites this paper
• Impact of Cannabidiol and Exercise on Clinical Outcomes and Gut Microbiota for Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors: A Case Report

  2024cites this paper
• Quantification and time course of subjective psychotropic and somatic effects of tetrahydrocannabinol – a prospective, single-blind, placebo-controlled exploratory trial in healthy volunteers

  2024cites this paper
• Cannabis use frequency and pain interference among people with HIV

  2023cites this paper
• Medical Cannabis: A Review from the American Society of Pain and Neuroscience

  2023cites this paper
• Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System

  2023influential citation
• Characterization and evaluation of nine Cannabis sativa chloroplast SNP markers for crop type determination and biogeographical origin on European samples.

  2023cites this paper
• Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

  2023cites this paper
• Medicinal plants for the treatment of neuropathic pain: A review of randomized controlled trials.

  2023cites this paper
• Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions

  2023influential citation
• Role of the gut-brain axis in HIV and drug abuse-mediated neuroinflammation

  2023cites this paper
• Moving Away from 12:12; the Effect of Different Photoperiods on Biomass Yield and Cannabinoids in Medicinal Cannabis

  2023cites this paper
• Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ9-THC)

  2023cites this paper
• An answered call for aid? Cannabinoid clinical framework for the opioid epidemic

  2023cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 3

  2023cites this paper
• Endocannabinoid System: Chemical Characteristics and Biological Activity

  2023cites this paper
• Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis

  2023cites this paper
• The impact of cannabinoids on inflammasome signaling in HIV-1 infection

  2023cites this paper
• Medical Cannabis in Hand Surgery: A Review of the Current Evidence.

  2023cites this paper
• Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research

  2023cites this paper
• Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership

  2023cites this paper
• Cannabinoids: Legal aspects, pharmacology, phytochemistry, probable targets from biological system, and therapeutic potential

  2022cites this paper
• Palliative cancer patients pain reduction methods during opioid epidemic era

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 4

  2022cites this paper
• Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy.

  2022cites this paper
• Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain

  2022cites this paper
• Developing Oligo Probes for Chromosomes Identification in Hemp (Cannabis sativa L.)

  2022cites this paper
• Cannabinoids—Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series

  2022cites this paper
• Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients

  2022cites this paper
• Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana

  2022cites this paper
• Chronic pain and substance use disorders among older sexual minority men living with HIV: Implications for HIV disease management across the HIV care continuum

  2022cites this paper
• The relationship between substance use and physical activity among people living with HIV, chronic pain, and symptoms of depression: a cross-sectional analysis

  2022cites this paper
• Ten reasons to consider cannabinoids in everyday clinical practice

  2022cites this paper
• Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot

  2022cites this paper
• Analyzing the Perspectives of Health Professionals and Legal Cannabis Users on the Treatment of Chronic Pain With Cannabidiol: Protocol for a Scoping Review

  2022cites this paper
• “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained

  2022cites this paper
• Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care

  2022cites this paper
• Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain

  2022cites this paper
• Cannabinoids: Therapeutic Use in Clinical Practice

  2022cites this paper
• Task-independent Acute Effects of delta-9-tetrahydrocannabinol on Human Brain Function and Its Relationship With Cannabinoid Receptor Gene Expression_ A Neuroimaging Meta-regression AnalysisShort title_ Acute effects of THC on the human brain

  2022cites this paper
• Cannabis use among patients with cutaneous lymphoma: A cross-sectional survey.

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3

  2022cites this paper
• Biological Effects of Cannabidiol on Human Cancer Cells: Systematic Review of the Literature.

  2022cites this paper
• Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)

  2022cites this paper
• Medical Marijuana From Medicine, Legal And Islamic Law Perspective: A Review

  2022cites this paper
• Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review

  2021influential citation
• Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies

  2021cites this paper
• Easier patient access to medical cannabis carries risks as well as benefits

  2021cites this paper
• The Role of Cannabidiol in Neurological Disorders.

  2021cites this paper
• Archaeobotanical evidence of the use of medicinal cannabis in a secular context unearthed from South China.

  2021cites this paper
• Reasons for Marijuana Use and Its Perceived Effectiveness in Therapeutic and Recreational Marijuana Users Among People Living with HIV in Florida

  2021cites this paper
• The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study.

  2021cites this paper
• Mini-review: The therapeutic role of cannabinoids in neuroHIV

  2021cites this paper
• Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis

  2021cites this paper
• Tetrahydrocannabinol (THC) exacerbates inflammatory bowel disease in adolescent and adult female rats.

  2021cites this paper
• Demand curve analysis of marijuana use among persons living with HIV.

  2021cites this paper
• People living with HIV and the emerging field of chronic pain—what is known about epidemiology, etiology, and management

  2021cites this paper
• Cannabinoids and Pain: The Highs and Lows.

  2021cites this paper
• Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects.

  2021cites this paper
• Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis

  2021influential citation
• Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series

  2021cites this paper
• Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: a neuroimaging meta-regression analysis

  2021cites this paper
• Proceedings of the 2021 Cannabis Clinical Outcomes Research Conference

  2021cites this paper
• Safety of Medical Cannabis in Neuropathic Chronic Pain Management

  2021influential citation
• TIBBİ KENEVİR VE SAĞLIK: FARMAKOLOJİK BİR DERLEME

  2021cites this paper
• Neuropathic Pain

  2021cites this paper
• Challenges for Clinical Cannabis and Cannabinoid Research in the United States.

  2021cites this paper
• Positive Toxicology Results Are Not Associated with Emergency Physicians’ Opioid Prescribing Behavior

  2021cites this paper
• Comment on: Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in patients with chronic pain

  2021cites this paper